Golden Arrow Merger Files Proxy for Deadline Extension Proposal

Healthcare-focused Golden Arrow Merger filed a definitive proxy and called a March 15 meeting for shareholders to vote on a proposal to push the SPAC’s termination deadline from March 19 to Dec. 19.

Golden Arrow raised $250 million in a March 2021 IPO to focus on healthcare or healthcare-related infrastructure industries in the United States and other developed countries.

The SPAC said it is in discussions with at least one potential target, but the board beleives it will need nine more months to bring a deal to closure.

Golden Arrow is led by CEO and CFO Timothy Babich, who founded and continues to manage private investment firm Nexxus Holdings. Babich was also the founder and chairman of FCM Bank, a European-based online challenger bank. Read more.

Total
0
Shares
Related Posts
OceanTech Acquisitions I
Read More

OceanTech Acquisitions I Appeals Nasdaq Delisting

In March, the original management team sold the sponsor holdings to a new team, which signed a definitive merger agreement with Israel-based Regentis Biomaterials at a $95 million valuation. However, the Nasdaq responded that the SPAC's minimum market value still had not been met within the complaince period, leading to the decision to suspend trading.